Tudor Financial Inc. lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 2.8% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 1,728 shares of the healthcare conglomerate’s stock after selling 49 shares during the period. Tudor Financial Inc.’s holdings in UnitedHealth Group were worth $905,000 at the end of the most recent reporting period.
Other large investors also recently made changes to their positions in the company. Fort Washington Investment Advisors Inc. OH grew its holdings in shares of UnitedHealth Group by 0.3% during the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock worth $277,641,000 after purchasing an additional 1,465 shares during the last quarter. Waycross Partners LLC lifted its stake in shares of UnitedHealth Group by 2.4% during the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock valued at $14,060,000 after acquiring an additional 658 shares during the period. Sherbrooke Park Advisers LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at $515,000. Full Sail Capital LLC lifted its stake in shares of UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after acquiring an additional 33 shares during the period. Finally, Soros Fund Management LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at $39,413,000. Institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Stock Down 1.6%
Shares of UnitedHealth Group stock opened at $313.39 on Friday. The business’s 50 day simple moving average is $386.66 and its 200 day simple moving average is $474.19. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The firm has a market cap of $284.28 billion, a PE ratio of 20.22, a P/E/G ratio of 1.37 and a beta of 0.45. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.
UnitedHealth Group Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be given a dividend of $2.21 per share. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.82%. UnitedHealth Group’s payout ratio is 37.02%.
Insiders Place Their Bets
In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the business’s stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the transaction, the chief executive officer now owns 10,398 shares of the company’s stock, valued at $3,171,390. The trade was a 5.36% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director John H. Noseworthy bought 300 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 14th. The shares were acquired at an average price of $312.16 per share, with a total value of $93,648.00. Following the completion of the purchase, the director now directly owns 6,063 shares in the company, valued at $1,892,626.08. This trade represents a 5.21% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 109,408 shares of company stock valued at $31,607,768 in the last 90 days. 0.28% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
UNH has been the topic of several research reports. Wolfe Research cut their price target on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating on the stock in a research note on Tuesday, May 20th. Robert W. Baird lowered UnitedHealth Group from an “outperform” rating to a “neutral” rating and set a $312.00 target price on the stock. in a research note on Wednesday. JPMorgan Chase & Co. cut their target price on UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating on the stock in a research note on Thursday, May 15th. HSBC reissued a “reduce” rating and issued a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Finally, TD Cowen lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price on the stock. in a research note on Monday, May 19th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $426.52.
View Our Latest Research Report on UnitedHealth Group
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- Dividend Capture Strategy: What You Need to Know
- IBM Up 10 Days in a Row: What’s Driving the Winning Streak?
- How to Calculate Return on Investment (ROI)
- Upstart Stock’s Bull Case Just Got a Lot Stronger
- What is the Hang Seng index?
- Higher Gulf Oil Output Puts These Energy Names in Play
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.